Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             251 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Abstract 1997
 33 Supplement 8 p. 2139-
1 p.
 artikel
2 A carbamate analogue of amsacrine with activity against non-cycling cells stimulates topoisomerase ii cleavage at dna sites distinct from those of amsacrine Baguley, B.C.
 1997
 33 Supplement 8 p. 272-279
8 p.
 artikel
3 Activation of immune effector cell cytolytic activity by the alkaloid derivative Ukrain (NSC631570) Liepins, A.
 1997
 33 Supplement 8 p. S26-
1 p.
 artikel
4 Adjuvant chema-radiotherapy of rectum carcinoma: Comparison of 12 months vs. 6 months chemotherapy Queißer, W.
 1997
 33 Supplement 8 p. S243-
1 p.
 artikel
5 A dose-controlled study of 153Sm-Ethylenediaminetetramethylenephosphonate (EDTMP) in the treatment of patients with painful bone metastase Resche, I.
 1997
 33 Supplement 8 p. 1583-1591
9 p.
 artikel
6 Alteration in NK cell activity during the progression of breast cancer and it modulation by cytokine Konjević, G.
 1997
 33 Supplement 8 p. S197-
1 p.
 artikel
7 alterations of the tumour suppressor gene DCC in Neuroblastoma Kong, X.-T
 1997
 33 Supplement 8 p. 1962-1965
4 p.
 artikel
8 Analysis of bcl-2 and p53 genes in patients with breast cancer Dueñas, A.
 1997
 33 Supplement 8 p. S11-
1 p.
 artikel
9 Analysis of candidate gene co-amplification with MYCN in neuroblastoma George, R.E
 1997
 33 Supplement 8 p. 2037-2042
6 p.
 artikel
10 An intronic deletion in TP53 gene causes exon 6 skipping in breast cancer Voglino, G.
 1997
 33 Supplement 8 p. 1479-1483
5 p.
 artikel
11 Antiblastic activity bifunctional platinum-6-mercaptopurin and monoclonal antibody conjugate Plotnikov, V.
 1997
 33 Supplement 8 p. S96-
1 p.
 artikel
12 Anti-idiotypes for immunotherapy of breast cancer — Tumor control in an in-vivo model Köhler, S.
 1997
 33 Supplement 8 p. S8-
1 p.
 artikel
13 Antimetastatic activity of viral oncolysates Urazova, L.
 1997
 33 Supplement 8 p. S90-
1 p.
 artikel
14 An unusual case of a renin-producing tumour of the fallopian tube Zabernigg, A.
 1997
 33 Supplement 8 p. 1709-
1 p.
 artikel
15 A phase II study of paclitaxel in platinum pretreated ovarian cancer. A hellenic cooperative oncology group study Aravantinos, G.
 1997
 33 Supplement 8 p. 160-163
4 p.
 artikel
16 A phase II study of topotecan given as a continuous 21-day infusion every 28 days in platinum pre-treated ovarian carcinoma Johnson, S.
 1997
 33 Supplement 8 p. S120-
1 p.
 artikel
17 A phase I trial of 5-day chronomodulated infusion of 5-fluorouracil and 1-folinic acid in patients with metastatic colorectal cancer Garufi, C.
 1997
 33 Supplement 8 p. 1566-1571
6 p.
 artikel
18 Apoptosls corrected proliferation fraction in childhood sarcoma shows binominal distribution suggestive of switch mechanism in proliferation control Ball, L.M.
 1997
 33 Supplement 8 p. S14-S15
2 p.
 artikel
19 A prospective randomlsed trial of protracted venous infusion (PVI) 5-FU with or without mitomycin C (MMC) in advanced colorectal cancer Ross, P.
 1997
 33 Supplement 8 p. S242-
1 p.
 artikel
20 A randomized trial of IFNα/IL-2 with or without CDDP in advanced melanoma: An EORTC melanoma cooperative group trial Keilholz, U.
 1997
 33 Supplement 8 p. S256-
1 p.
 artikel
21 Are disseminated tumor cells detected by RT-PCR In patients with colorectal cancer of prognostic value? Vogel, I.
 1997
 33 Supplement 8 p. S160-S161
2 p.
 artikel
22 Are patients with lymphoedema being given enough information to manage their own programme of care? Green, Gene
 1997
 33 Supplement 8 p. S322-
1 p.
 artikel
23 Aromatase inhibitors for breast cancer—further progress Rubens, R.D.
 1997
 33 Supplement 8 p. 989-990
2 p.
 artikel
24 A rule based system for prediction of radiation induced tissue injury Busch, M.
 1997
 33 Supplement 8 p. S106-
1 p.
 artikel
25 A seven-years experience with implantable devices for regional hepatic arterial chemotherapy: Usability time, incidence and management of complications Formentini, A.
 1997
 33 Supplement 8 p. S164-S165
2 p.
 artikel
26 Assessing patient satisfaction with radiation therapy information Samant, A.
 1997
 33 Supplement 8 p. S312-
1 p.
 artikel
27 Attributable risks for hepatocellular carcinoma in Northern Italy Braga, C.
 1997
 33 Supplement 8 p. 629-634
6 p.
 artikel
28 Axillary dissection — How and when do I do it? Salvadori, B.
 1997
 33 Supplement 8 p. S77-
1 p.
 artikel
29 Breast cancer and HIV infection: Two case reports Cuvier, C.
 1997
 33 Supplement 8 p. 507-508
2 p.
 artikel
30 Breast cancer in patients treated for hodgkin’s disease: clinical and pathological analysis of 76 cases in 63 patients 1 1 Presented in Part at the ECCO 8 Conference, Paris, 2 November, 1995. Cutuli, B
 1997
 33 Supplement 8 p. 2315-2320
6 p.
 artikel
31 Cancer in the elderly — Are there different needs for information? An evaluation of calls to the German cancer information service Wilcke, S.
 1997
 33 Supplement 8 p. S61-S62
2 p.
 artikel
32 Cancer patient information and support Keskinen, Leena
 1997
 33 Supplement 8 p. S62-
1 p.
 artikel
33 Cancer phenotype in 19 families with TP53 mutations Birch, J.M.
 1997
 33 Supplement 8 p. S12-
1 p.
 artikel
34 Cancer research priorities: The discrepancy between research needs and research output Stalpers, Lukas J.A.
 1997
 33 Supplement 8 p. S128-
1 p.
 artikel
35 Carboplatin (CBDCA) + radiotherapy (RT) vs RT in inoperable stage III–IV head and neck (HN) carcinoma Airoldi, M.
 1997
 33 Supplement 8 p. S187-
1 p.
 artikel
36 Cardioprotective efficacy of amifostine (WR-2721) in adriamycine-treated rats Dobrić, S.
 1997
 33 Supplement 8 p. S21-
1 p.
 artikel
37 Changes in tumor oxygenation in split course radiochemotherapy (RCTh) Stadler, P.
 1997
 33 Supplement 8 p. S185-S186
2 p.
 artikel
38 Chemo-radiotherapy for locally advanced head and neck cancer—long-term results of a phase II trial Dinges, S.
 1997
 33 Supplement 8 p. 1152-1155
4 p.
 artikel
39 Chemotherapy for metastatic breast cancer —When is enough enough? Stockler, M.
 1997
 33 Supplement 8 p. 2147-2148
2 p.
 artikel
40 CHOP-based Chemotherapy is as effective as alternating PEEC/CHOP chemotherapy in a randomised trial in high-grade non-Hodgkin's lymphoma Cameron, D.A
 1997
 33 Supplement 8 p. 1195-1201
7 p.
 artikel
41 8 -CI-cAMP induction of differentiation and apoptosis in Y-79 human retinoblastoma cell line Fasslna, G.
 1997
 33 Supplement 8 p. S181-S182
2 p.
 artikel
42 Clinical and immunomodulatory effects of repetitive 2-day cycles of high-dose continuous infusion IL-2 Engelhardt, M.
 1997
 33 Supplement 8 p. 1050-1054
5 p.
 artikel
43 Clinical and pathological response to primary chemotherapy in operable breast cancer Chollet, P.
 1997
 33 Supplement 8 p. 862-866
5 p.
 artikel
44 Clinical benefit with cisplatin, hydroxyurea and 5-fluorouracil/ leucovorin in advanced pancreatic adenocarcinoma Raymond, E.
 1997
 33 Supplement 8 p. 696-697
2 p.
 artikel
45 Clinical course, prognosis and therapy of bone metastases in breast cancer patients Diel, I.J.
 1997
 33 Supplement 8 p. S150-
1 p.
 artikel
46 Clofazimlne and B4121 sensitize an intrinsically resistant human colon cancer cell line to paclitaxel and taxotere Jooné, G.
 1997
 33 Supplement 8 p. S179-
1 p.
 artikel
47 Co-expression of MDR-associated markers, including P-170, MRP and LRP and cytoskeletal proteins, in three resistant variants of the human ovarian carcinoma cell line, OAW42 Moran, E.
 1997
 33 Supplement 8 p. 652-660
9 p.
 artikel
48 COLLATE: A collaborative authoring tool for the development of clinical oncology guideline Renaud-Salis, J.L.
 1997
 33 Supplement 8 p. S83-S84
2 p.
 artikel
49 Combination of oral idarubicin and prednimustine in advanced breast cancer: a phase II study Barnadas, A.
 1997
 33 Supplement 8 p. 312-315
4 p.
 artikel
50 Comparison of histological results from the resection of residual masses at different sites after chemotherapy for metastatic non-seminomatous germ cell tumours Hartmann, J.T.
 1997
 33 Supplement 8 p. 843-847
5 p.
 artikel
51 Complementary therapies and cancer care McNamara, P.
 1997
 33 Supplement 8 p. S318-
1 p.
 artikel
52 Consistent safety and efficacy results in 2 study populations treated with irinotecan (CPT-11) for metastatic colorectal cancer (MCRC) resistant to 5-FU Guimbaud, R.
 1997
 33 Supplement 8 p. S165-
1 p.
 artikel
53 Contra: Mooi, W.J.
 1997
 33 Supplement 8 p. 523-524
2 p.
 artikel
54 C reactive protein and albumin in pancreatic cancer Pugliese, P.
 1997
 33 Supplement 8 p. S282-
1 p.
 artikel
55 Critical overview concerning new agents that block invasion/metastasis Burger, Max M.
 1997
 33 Supplement 8 p. S47-
1 p.
 artikel
56 Current developments in the treatment of chronic myeloid leukemia Cornelissen, J.J.
 1997
 33 Supplement 8 p. S226-
1 p.
 artikel
57 Cytosolic phospholipase A2, cyclo-oxygenases and arachidonate in human stomach tumours Soydan, A.S.
 1997
 33 Supplement 8 p. 1508-1512
5 p.
 artikel
58 Dendritic cells for autologous tumor vaccination in chronic myeloid leukemia Westermann, J.
 1997
 33 Supplement 8 p. S30-
1 p.
 artikel
59 Detection of Neuroblastoma cells in CD34+ selected peripheral stem cells using a combination of tyrosine hydroxylase nested RT–PCR and anti-Ganglioside GD2 immunocytochemistry Lode, H.N
 1997
 33 Supplement 8 p. 2024-2030
7 p.
 artikel
60 Detection of tumor progression in NSCLC stage IIIB/IV patients by serial measurement of CYFRA 21-1, TPA-M. TPS, and CEA Ebert, W.
 1997
 33 Supplement 8 p. S46-S47
2 p.
 artikel
61 Determination of DNA damage in uranium miners Plappert, U.
 1997
 33 Supplement 8 p. S129-
1 p.
 artikel
62 Differential responses to chemoimmunotherapy in patients with metastatic malignant melanoma Mainwaring, P.N.
 1997
 33 Supplement 8 p. 1388-1392
5 p.
 artikel
63 Differing percentages of p53 gene mutations, correlation of p53 protein with point mutations and genetic instability in right and left colon cancer LLeonart, M.
 1997
 33 Supplement 8 p. S163-
1 p.
 artikel
64 DNA-Topoisomerase I, a new target for the treatment of neuroblastoma Vassal, G
 1997
 33 Supplement 8 p. 2011-2015
5 p.
 artikel
65 Docetaxel in combination with doxorubicin or vinorelbine Diéras, V.
 1997
 33 Supplement 8 p. S20-S22
3 p.
 artikel
66 Dose scheduling & drug tolerability in phase II studies of gemcitabine and cisplstin chemotherapy for non-small cell lung cancer Abratt, R.P.
 1997
 33 Supplement 8 p. S236-S237
2 p.
 artikel
67 ‘Dosimetric breast size’: A new and useful parameter for the prediction of local recurrence after breast conservative treatment 1 1 Presented in part at the second Joint Meeting on Senology, Florence, 21 March 1997. Cutuli, B
 1997
 33 Supplement 8 p. 2432-2434
3 p.
 artikel
68 Doxifluridine in colorectal cancer patients resistant to 5-fluorouracil (5-FU) containing regimens Bajetta, E.
 1997
 33 Supplement 8 p. 687-690
4 p.
 artikel
69 Economic costs of high-close chemotherapy with peripheral blood stem cell rescue Isla, D.
 1997
 33 Supplement 8 p. S95-
1 p.
 artikel
70 Effect of bleomycin and asparaginase on leukotriene production in vitro and in vivo Geuenich, Susanne
 1997
 33 Supplement 8 p. S23-
1 p.
 artikel
71 Effect of hypoxia on tumour growth and metastasis formation studied in chick embryo Höper, J.
 1997
 33 Supplement 8 p. S28-
1 p.
 artikel
72 Efficacy and safety of oral granisetron vs IV ondansetron in prevention of moderately emetogenic chemotherapy-induced nausea and vomiting Perez, E.A.
 1997
 33 Supplement 8 p. S18-
1 p.
 artikel
73 Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma Schweinitz, D.von
 1997
 33 Supplement 8 p. 1243-1249
7 p.
 artikel
74 EMEA boast 36 products in 26 months 1997
 33 Supplement 8 p. 512-513
2 p.
 artikel
75 EONS distinguished merit award goes to Dr Agnes Glaus 1997
 33 Supplement 8 p. 985-
1 p.
 artikel
76 EORTC board for 1997–2000 1997
 33 Supplement 8 p. 802-803
2 p.
 artikel
77 EORTC phase II study of daily oral linomide in metastatic renal cell carcinoma patients with good prognostic factors de Wit, R.
 1997
 33 Supplement 8 p. 493-495
3 p.
 artikel
78 Epidemiology and screening of colorectal cancer Faivre, J.
 1997
 33 Supplement 8 p. S217-
1 p.
 artikel
79 Ethical dilemma's in the care of cancer patients Willems, Y.
 1997
 33 Supplement 8 p. S306-
1 p.
 artikel
80 Etoposide, leucovorin and fluorouracil (ELF) in advanced gastric cancer: Our experience Scimone, A.
 1997
 33 Supplement 8 p. S283-
1 p.
 artikel
81 Evaluation of body composition in patients with lung cancer by bioelectric impedance (BIA) Toso, S.
 1997
 33 Supplement 8 p. S58-S59
2 p.
 artikel
82 Evidence-based medicine and the cochrane collaboration: A new approach to medical decision-making in cancer therapy Rüther, A.
 1997
 33 Supplement 8 p. S130-
1 p.
 artikel
83 Evolution of biological parameter in patients with breast cancer treated with primary chemotherapy Donadio, M.
 1997
 33 Supplement 8 p. S198-S199
2 p.
 artikel
84 Exploiting hypoxia: Bioreductive drugs and gene therapy approache Stratford, Ian J.
 1997
 33 Supplement 8 p. S220-
1 p.
 artikel
85 Expression of heat shock protein 72 in renal cell carcinoma: Possible role and prognostic implications in cancer patients Santarosa, M.
 1997
 33 Supplement 8 p. 873-877
5 p.
 artikel
86 Expression of macrophage colony-stimulating factor (M-CSF), interleukin-6 (il-6), interleukin-lβ (IL-Iβ), interleukin-11 (IL-11) and tumour necrosis factor-α (TNF-α) in p53-characterised human ovarian carcinomas Asschert, J.G.W.
 1997
 33 Supplement 8 p. 2246-2251
6 p.
 artikel
87 Feasibility and phase II study of combined modality treatment with accelerated radiotherapy and chemotherapy in patients with locally advanced inoperable carcinoma of the pancreas Berns, T.
 1997
 33 Supplement 8 p. S277-
1 p.
 artikel
88 Feasibility of paclitaxel in a patient with anthracyclineinduced congestive heart failure Colleoni, M.
 1997
 33 Supplement 8 p. 321-322
2 p.
 artikel
89 Fibroblast contamination in assays of tumour radio-sensitivity Stausbøl-Grøn, B.
 1997
 33 Supplement 8 p. S25-
1 p.
 artikel
90 Final results of a phase III clinical trial on adjuvant intraportal infusion with heparin and 5-fluorouracil (5-FU) in resectable colon cancer (EORTC GITCCG 1983–1987) Nitti, D
 1997
 33 Supplement 8 p. 1209-1215
7 p.
 artikel
91 Follow-up of patients operated on for stage I melanoma: the report of the French consensus conference, 1995. English translation of the French document, first published in the Annals de Dermatologie et de Vénéréologie 1995, vol. 122, pp. 250–258 Saiag, P.
 1997
 33 Supplement 8 p. 331-337
7 p.
 artikel
92 Frequent allelic losses on chromosome 13q in human male breast carcinomas Wingren, S
 1997
 33 Supplement 8 p. 2393-2396
4 p.
 artikel
93 Gel formula dressing in the care of acute skin damage by radiation in head and neck cancer patients Chen, Yu-Ping
 1997
 33 Supplement 8 p. S302-
1 p.
 artikel
94 Genome wide search for genetic damage in p53 transgenic mouse lung tumours reveals consistent loss of chromosome 4 Wu, M.-C.
 1997
 33 Supplement 8 p. 1677-1684
8 p.
 artikel
95 Granulocyte-macrophage colony-stimulating factor improves immunological parameters in patients with refractory solid tumours receiving second-line chemotherapy: Correlation with clinical responses Baxevanis, C.N
 1997
 33 Supplement 8 p. 1202-1208
7 p.
 artikel
96 HDR-brachytherapy is an effective treatment modality in primary treatment of inoperable patients with endometrial carcinoma Knocke, T.H.
 1997
 33 Supplement 8 p. S207-
1 p.
 artikel
97 Heterozygosity for a point mutation in an invariant splice donor site of dihydropyrimidine dehydrogenase and severe 5-fluorouracil related toxicity Van Kuilenburg, A.B.P.
 1997
 33 Supplement 8 p. 2258-2264
7 p.
 artikel
98 High dose methotrexate (HDMTX) pharmacokinetic profile in osteosarcoma patients Comandone, A.
 1997
 33 Supplement 8 p. S249-
1 p.
 artikel
99 Histopathological and biochemical evaluation of wound healing following preoperative irradiation, chemo-irradlatlon and intra-peritoneal 5-fluorouracll (5-FU) in the rat Juzu, M.A.
 1997
 33 Supplement 8 p. S103-S104
2 p.
 artikel
100 Home sweet home! Home care technology for patients with cancer or serious infectious diseases van Boxte, A.J.H.
 1997
 33 Supplement 8 p. S327-
1 p.
 artikel
101 Hospital closed-circuit TV as an educational strategy to meet the learning needs of cancer patient Johow, V.
 1997
 33 Supplement 8 p. S310-
1 p.
 artikel
102 How to perform effective IL-2 therapy Den Otter, Willem
 1997
 33 Supplement 8 p. S87-S88
2 p.
 artikel
103 5-HT3 receptor antagonists: Differences and similarities Roila, F.
 1997
 33 Supplement 8 p. 1364-1370
7 p.
 artikel
104 IDEC-C2B8-induced B cell depletion is not associated with significant immune suppression or infection White, C.A.
 1997
 33 Supplement 8 p. S266-
1 p.
 artikel
105 Immediate results of the locally advanced larynx cancer T3–4N0–3M0 treatment using non-conventional dose fractionation radiotherapy Slobina, E.
 1997
 33 Supplement 8 p. S193-
1 p.
 artikel
106 Immunohistochemical examination of the expression of O 6-methylguanine-DNA methyltransferase in human melanoma metastases Egyházi, S.
 1997
 33 Supplement 8 p. 129-134
6 p.
 artikel
107 Immunoreactive detection of parathormone related protein (PTHrP) in primary breast cancer is a good prognostic factor for subsequent bone metastase Gollan, Ch.
 1997
 33 Supplement 8 p. S195-
1 p.
 artikel
108 Improving quality of life in patients with non-small cell lung cancer: Research experience with gemcitabine Thatcher, N.
 1997
 33 Supplement 8 p. S8-S13
6 p.
 artikel
109 Intensified salvage therapy for germ cell cancer using sequential cycles of high dose carboplatin/etoposlde/cyclo-phosphamlde (CEC) Harstrick, A.
 1997
 33 Supplement 8 p. S40-
1 p.
 artikel
110 Intensive radiochemotherapy (RCT) with amifostine (A) in head and neck (H&N) cancer Büantzel, J.
 1997
 33 Supplement 8 p. S17-S18
2 p.
 artikel
111 International cancer news 1997
 33 Supplement 8 p. 1159-1167
9 p.
 artikel
112 Interval cancers and cancers in non-attenders in the östergötland mammographic screening programme. Duration between screening and diagnosis, S-phase fraction and distant recurrence Vitak, B.
 1997
 33 Supplement 8 p. 1453-1460
8 p.
 artikel
113 Intratumor (IT) gene transfer with recombinant adenovlral (rAd) vectors in lung cancer (LC) patients (PTS): The institut Gustave Roussy (IGR) experience Tursz, T.
 1997
 33 Supplement 8 p. S136-
1 p.
 artikel
114 In vivo evaluation of the lrinotecan-oxaliplatin comblnation Bissery, M.C.
 1997
 33 Supplement 8 p. S177-
1 p.
 artikel
115 In vivo resistance of murine leukemia P388 towards piatinum complexes Goncharova, S.
 1997
 33 Supplement 8 p. S181-
1 p.
 artikel
116 Ireland 1997
 33 Supplement 8 p. 4-
1 p.
 artikel
117 Koilocytotic lesions and cervical cancer in Moldova: An morphoepidemiological study Chemy, A.P.
 1997
 33 Supplement 8 p. S211-
1 p.
 artikel
118 Letter to the Editor: Comments on Health-related Quality of Life of Adults Surviving Malignancies in Childhood, Apajasalo et al., Eur J Cancer, 32A, No. 8, pp. 1354-1358, 1996 Barr, R.D.
 1997
 33 Supplement 8 p. 506-507
2 p.
 artikel
119 Localised soft tissue sarcomas. Treatment results and prognostic factors Cemea, Dana
 1997
 33 Supplement 8 p. S115-
1 p.
 artikel
120 Long-term, totally implantable central venous access ports connected to a Groshong atheter for chemotherapy of solid tumours: Experience from 178 cases using a single type of device Biffi, R
 1997
 33 Supplement 8 p. 1190-1194
5 p.
 artikel
121 Loss of heterozygosity for chromosome 1p in familial neuroblastoma Tonini, G.P
 1997
 33 Supplement 8 p. 1953-1956
4 p.
 artikel
122 Low toxicity (TOX) of a prolonged infusion of gemcltablne (GEM) Späth-Schwalbe, E.
 1997
 33 Supplement 8 p. S253-
1 p.
 artikel
123 Lung cancer in the elderly Gridelli, C
 1997
 33 Supplement 8 p. 2313-2314
2 p.
 artikel
124 Magnetic resonance imaging of bone marrow versus biopsy in malignant lymphoma Özgüroğlu, M.
 1997
 33 Supplement 8 p. S270-
1 p.
 artikel
125 Management and survival of ovarian cancer patients in South East England Wolfe, C.D.A.
 1997
 33 Supplement 8 p. 1835-1840
6 p.
 artikel
126 Medroxyprogesterone acetate reduces the in vitro production of cytokines and serotonin involved in anorexia/cachexia and emesis by peripheral blood mononuclear cells of cancer patients Mantovani, G.
 1997
 33 Supplement 8 p. 602-607
6 p.
 artikel
127 Modulation of cis-diamminedichloroplatinum (II) accumulation and cytotoxicity by spermine in sensitive and resistant human ovarian carcinoma cells Marverti, G.
 1997
 33 Supplement 8 p. 669-675
7 p.
 artikel
128 Molecular strategies to generate tumor vaccines for non-Hodgkin's lymphoma Hallek, M.
 1997
 33 Supplement 8 p. S52-
1 p.
 artikel
129 Monoclonal antibodies in combination with growth factors and chemotherapeutics Mellstedt, H.
 1997
 33 Supplement 8 p. S69-
1 p.
 artikel
130 Morbidity of external beam irradiation in patients with locally advanced prostate cancer: Analysis of our experience Pęczkowski, P.
 1997
 33 Supplement 8 p. S33-
1 p.
 artikel
131 Navelbine (NVB) and Doxorubicin (DX) both at 25 mg/m2, on days 1 & 8 for the management of advanced breast cancer (ABC) Anelli, A.
 1997
 33 Supplement 8 p. S151-
1 p.
 artikel
132 Neurological monitoring of neurotoxicity induced by paclitaxel/cisplatin chemotherapy Berger, T.
 1997
 33 Supplement 8 p. 1393-1399
7 p.
 artikel
133 Non-small cell lung cancer: How exsive should surgery be? Schirren, J.
 1997
 33 Supplement 8 p. S287-
1 p.
 artikel
134 No overall risk breast cancer with induced abortions 1997
 33 Supplement 8 p. 514-
1 p.
 artikel
135 Norway 1997
 33 Supplement 8 p. 805-
1 p.
 artikel
136 Novel antibody-based fusion proteins in cancer treatment Begent, RHJ
 1997
 33 Supplement 8 p. S39-
1 p.
 artikel
137 Occupational radiation carcinogenesis (overview) Miller, A.B.
 1997
 33 Supplement 8 p. S7-S9
3 p.
 artikel
138 Oncology nursing — Approaching a new millennium Glaus, A.
 1997
 33 Supplement 8 p. S305-
1 p.
 artikel
139 OP6. Costs of care in a randomised trial of early hospital discharge after surgery for breast cancer Bonnema, J
 1997
 33 Supplement 8 p. S2-S3
2 p.
 artikel
140 OP33. Determining the importance of specific symptoms for the economic evaluation of advanced prostate cancer therapies Yabroff, KR
 1997
 33 Supplement 8 p. S13-
1 p.
 artikel
141 Optimized detection of 5-S-cysteinyldopa (5-S-CD) in serum of melanoma patients: A new marker of metastatic Stockfleth, E.
 1997
 33 Supplement 8 p. S257-
1 p.
 artikel
142 Optimizing the efficacy of epirubicin as an intravesical chemotherapy agent. Can it be buffered to ph 8? Inman, L.
 1997
 33 Supplement 8 p. S248-
1 p.
 artikel
143 Outome of advanced epithelial ovarian cancer in women under 40 years Pires de Miranda, M.
 1997
 33 Supplement 8 p. S118-
1 p.
 artikel
144 Oxaliplatin/cisplatin (L-OHP/CDDP) combination in heavily pretreated ovarian cancer Soulié, P.
 1997
 33 Supplement 8 p. 1400-1406
7 p.
 artikel
145 Paclitaxel by 3-H infusion and carboplatin in anthracycline-resistant advanced breast cancer. A phase II study conducted by the hellenic cooperative oncology group Fountzilas, G.
 1997
 33 Supplement 8 p. 1893-1895
3 p.
 artikel
146 Paclitaxel (PX) — Carboplatin (CBP) versus cyclophosphamide (CTX)-carboplatin supported by G-CSF as first line chemotherapy in figo III–IV ovarian carcinoma (O.C.) Polyzos, A.
 1997
 33 Supplement 8 p. S122-
1 p.
 artikel
147 Paediatric oncology update series 1997
 33 Supplement 8 p. 238-
1 p.
 artikel
148 Pain management in cancer patient at home: The role and view of patient and professional Duijnhouwer, E.
 1997
 33 Supplement 8 p. S52-
1 p.
 artikel
149 Patients' perceptions of bone marrow transplantation Thain, Colin
 1997
 33 Supplement 8 p. S299-
1 p.
 artikel
150 p53 expression is of independent predictive value in lymph node-negative breast carcinoma Fresno, M
 1997
 33 Supplement 8 p. 1268-1274
7 p.
 artikel
151 PGP and growth factor expression is cell cycle dependent; Expression and function is modulated by sequential TMX and IFN Seymour, L.
 1997
 33 Supplement 8 p. S177-
1 p.
 artikel
152 Pharmacokinetics and tolerance of vinorelbine in elderly patients with metastatic breast cancer Sorio, R.
 1997
 33 Supplement 8 p. 301-303
3 p.
 artikel
153 Phase II study of 21 day schedule oral etoposide in children Davidson, A.
 1997
 33 Supplement 8 p. 1816-1822
7 p.
 artikel
154 Phase II study of weekly high-dose cisplatin for six cycles in patients with locally advanced squamous cell carcinoma of the head and neck Planting, A.S.T.
 1997
 33 Supplement 8 p. 61-65
5 p.
 artikel
155 Phase II trial of i.v. navelbine (NVB) and cisplatin (CDDP) in inoperable locally advanced or disseminated NSCLC Goedhals, L.
 1997
 33 Supplement 8 p. S239-
1 p.
 artikel
156 Phase II trial of rhIL-6 (Interleukin-6) prior to and concurrently with VAD (vincristine, doxorubicin and dexamethasone) chemotherapy for patients with multiple myeloma Young, R.I.
 1997
 33 Supplement 8 p. 307-311
5 p.
 artikel
157 Phase II trials of docetaxel (taxotere®) in advanced ovarian cancer—an updated overview Kaye, S.B.
 1997
 33 Supplement 8 p. 2167-2170
4 p.
 artikel
158 Phase I study of paclitaxel (P) combined with 14-day topotecan (T) Continuous IV (CIV) infusion in previously treated and untreated patients (PTS) Hochster, H.
 1997
 33 Supplement 8 p. S250-
1 p.
 artikel
159 Phase I study of the biodistribution, pharmacokinetics and immunogenicity of 111In-hCTMO1 (CDP671) ± predosing with unlabelled hCTMO1 in patients (pts) with lung cancer Verrill, M.
 1997
 33 Supplement 8 p. S246-
1 p.
 artikel
160 Plasma sialic acid as a marker of the effect of the treatment on metastatic colorectal cancer Painbeni, T.
 1997
 33 Supplement 8 p. 2216-2220
5 p.
 artikel
161 Platinum (II) complexes with phosphine-ferrocene containing ligands and their in vitro activity against leukemia AI-Allaf, Talal A.K.
 1997
 33 Supplement 8 p. S94-
1 p.
 artikel
162 Pooled analysis of topotecan (T) in the second-line treatment of patients (pts) with sensitive small cell lung cancer (SCLC) Eckardt, J.
 1997
 33 Supplement 8 p. S230-
1 p.
 artikel
163 PP17. An economic comparison of inpatient versus outpatient treatment of febrile neutropenia in a pediatric oncology ward Crott, R
 1997
 33 Supplement 8 p. S20-S21
2 p.
 artikel
164 PP48. A review of the pharmacoeconomic research on Gemcitabine (GemzarTM) in the treatment of advanced non-small cell lung cancer Minshall, ME
 1997
 33 Supplement 8 p. S32-
1 p.
 artikel
165 PP62. Cost/effectiveness assessment of cytogenetic and molecular biology analysis for acute leukemia's prognosis Tonnaire, G
 1997
 33 Supplement 8 p. S37-
1 p.
 artikel
166 PP14. Cost of serious adverse drug reactions related to anti-cancer chemotherapy Couffignal, AL
 1997
 33 Supplement 8 p. S19-
1 p.
 artikel
167 PP46. Economies of scale and technological efficiency in state-wide cancer detection programs Mansley, EC
 1997
 33 Supplement 8 p. S31-
1 p.
 artikel
168 PP31. The relative economics of screening for colorectal cancer, breast cancer and cervical cancer Gvrd-Hansen, D
 1997
 33 Supplement 8 p. S25-S26
2 p.
 artikel
169 Precision of fractionated stereotactic conformation radiotherapy of brain tumours Kortmann, R.D.
 1997
 33 Supplement 8 p. S102-
1 p.
 artikel
170 Predicting response in head and neck cancer: The search for the holy grall Coucke, Philippe A.
 1997
 33 Supplement 8 p. S289-S290
2 p.
 artikel
171 Predictive and prognostic factors — Clinical relevance Scholl, S.
 1997
 33 Supplement 8 p. S134-
1 p.
 artikel
172 Preliminary results of a randomised comparative phase III trial of topotecan versus CAV as second-line therapy of small cell lung cancer Clarke, P.
 1997
 33 Supplement 8 p. S228-
1 p.
 artikel
173 Preliminary results of a randomised study using WR-2721 in radiation therapy alone in patients with head and neck cancer Strnad, V.
 1997
 33 Supplement 8 p. S189-
1 p.
 artikel
174 Pretreatment predictors of metastatic potential verified at autopsy in patients (pts) with inoperable non-small cell lung cancer (NSCLC) Stenbygaard, L.
 1997
 33 Supplement 8 p. S232-
1 p.
 artikel
175 Primary chemotherapy for early breast cancer: A revolution in progress Smith, I.E.
 1997
 33 Supplement 8 p. S134-
1 p.
 artikel
176 Prognostic factors in the management of clinical stage I (CS I) nonsemlnomatous germ ceil tumors of the testis (NSGCTT) Ondruš, D.
 1997
 33 Supplement 8 p. S43-
1 p.
 artikel
177 Prognostic significance of axillary lymph node histology (pN) after neoadjuvant therapy for locally advanced breast cancer (LABC) Vitoc, C.
 1997
 33 Supplement 8 p. S151-
1 p.
 artikel
178 Prognostic significance of monoclonal antibody MIB-1 in early stage larynx carcinoma Betten, Th.
 1997
 33 Supplement 8 p. S187-
1 p.
 artikel
179 Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: Results of a multicentre randomised trial Gregor, A.
 1997
 33 Supplement 8 p. 1752-1758
7 p.
 artikel
180 Prophylactic thyroidectomy in MEN IIA gene carriers — An intervention with a justifiable morbidity? Hotz, H.G.
 1997
 33 Supplement 8 p. S273-
1 p.
 artikel
181 Prospects with docetaxel in the treatment of patients with breast cancer Marry, M.
 1997
 33 Supplement 8 p. S26-S29
4 p.
 artikel
182 Protocolized administration of naso-gastric tube feeding in children with cancer: Effects on nutritional status Den Broeder, E.
 1997
 33 Supplement 8 p. S56-
1 p.
 artikel
183 Pseudocontinent perineal colostomy following abdominoperineal resection: Technique and findings in 40 patients Dubé, P.
 1997
 33 Supplement 8 p. S168-S169
2 p.
 artikel
184 p53 Status as potential predictor for response to chemotherapy in locally advanced gastric cancer Cascinu, S.
 1997
 33 Supplement 8 p. S276-
1 p.
 artikel
185 Radiotherapy with carbogen breathing and nicotinamide in locally advanced non-small cell lung cancer (NSCLC) Yavuz, A.A.
 1997
 33 Supplement 8 p. S101-S102
2 p.
 artikel
186 Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer Bleiberg, H
 1997
 33 Supplement 8 p. 1216-1220
5 p.
 artikel
187 Rapid generation of human antibodies against tumour associated antigens Knappik, A.
 1997
 33 Supplement 8 p. S43-
1 p.
 artikel
188 Recent developments in radiotherapy; do nurses really meet patients needs? Wells, M.
 1997
 33 Supplement 8 p. S337-
1 p.
 artikel
189 Recently activated EORTC protocols 1997
 33 Supplement 8 p. 176-
1 p.
 artikel
190 Recurrent ifosfamide-induced hyponatraemia Kirch, C
 1997
 33 Supplement 8 p. 2438-2439
2 p.
 artikel
191 Reliability of cancer registration data Stiller, C.A.
 1997
 33 Supplement 8 p. 812-814
3 p.
 artikel
192 Response to primary chemotherapy of breast cancer Junkermann, D.
 1997
 33 Supplement 8 p. S147-
1 p.
 artikel
193 Response to radiotherapy of human uterine cervix carcinoma is not correlated with rearrangements of the HA-ras-1 and/or c-myc genes Polischouk, A.G.
 1997
 33 Supplement 8 p. 942-949
8 p.
 artikel
194 Retrospective analysis of 30 intracranial ependymoma Koçak, Z.
 1997
 33 Supplement 8 p. S202-
1 p.
 artikel
195 Review of recent trials of chemotherapy for advanced breast cancer: the taxanes Clemons, M.
 1997
 33 Supplement 8 p. 2183-2193
11 p.
 artikel
196 Risk factors for colorectal cancer same in those with and without family history 1997
 33 Supplement 8 p. 983-
1 p.
 artikel
197 Risk of a second germ cell cancer after treatment of a primary germ cell cancer in 2201 norwegian male patients Hoff Wanderås, E.
 1997
 33 Supplement 8 p. 244-252
9 p.
 artikel
198 Role of 99mTc-Sestamibi for diagnosis, staging and follow up of patient with lung cancer Sergieva, S.
 1997
 33 Supplement 8 p. S238-
1 p.
 artikel
199 RT-PCR detection of melanoma cells in peripheral blood stem cell harvests of patients with metastatic malignant melanoma Schrader, A.
 1997
 33 Supplement 8 p. S260-
1 p.
 artikel
200 Serum levels of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in patients (pts) with soft tissue sarcoma (STS) Graeven, U.
 1997
 33 Supplement 8 p. S112-
1 p.
 artikel
201 Six years experience using inhalatory interleukin-2 in pulmonary metastatic renal cell carcinoma Huland, E.
 1997
 33 Supplement 8 p. S86-
1 p.
 artikel
202 Soft tissues granular cell tumor: Disease description and treatment Dubé, P.
 1997
 33 Supplement 8 p. S114-
1 p.
 artikel
203 Somatostatin in neuroblastoma and ganglioneuroma Kogner, P
 1997
 33 Supplement 8 p. 2084-2089
6 p.
 artikel
204 Stereotactic radiotherapy for brain tumours-fact & fiction Brada, M.
 1997
 33 Supplement 8 p. S144-
1 p.
 artikel
205 Stimulation of CD 40 up-regulates costimulatory molecules on chronic B-lymphocytic leukemia cells and induces efficient killing of stimulated and not-stimulated B-CLL by cytolytic effector cells Buhamnn, R.
 1997
 33 Supplement 8 p. S19-
1 p.
 artikel
206 Study of two intravenous schedules of clodronate (CL) in patients with bone metastases Semiglazov, V.V.
 1997
 33 Supplement 8 p. S55-
1 p.
 artikel
207 Subcutaneous (SC) interleukin-2 (IL-2) plus alpha interferon (IFN-α) and 5 fluorouracil (5 FU) in out-patients (pts) with metastatic renal cell carcinoma (MRCC). Scapp II trial Tourani, J.M.
 1997
 33 Supplement 8 p. S36-
1 p.
 artikel
208 Subject index 1997
 33 Supplement 8 p. S375-S380
6 p.
 artikel
209 Successful postsurgical immunotherapy of patients with III–IV stages of cancer Tarasov, V.
 1997
 33 Supplement 8 p. S29-
1 p.
 artikel
210 Survival in renal cell carcinoma (RCC)— A randomised evaluation of tamoxifen versus interleukin-2, α-interferon (leukocyte) and tamoxifen Henriksson, R.
 1997
 33 Supplement 8 p. S37-
1 p.
 artikel
211 Symptom occurrence and symptom distress in chemotherapy patients evaluated by patients and nurses Tanghe, A.
 1997
 33 Supplement 8 p. S298-S299
2 p.
 artikel
212 Tandem high-dose therapy with ifosfamide, epirubicin, carboplatin and peripheral blood stem cell support is an effective adjuvant treatment for high-risk primary breast cancer Haas, R.
 1997
 33 Supplement 8 p. 372-378
7 p.
 artikel
213 Taxotere and clsplatln In metastatic urothelial cancer: A phase II study Sengeløv, L.
 1997
 33 Supplement 8 p. S30-
1 p.
 artikel
214 Telomerase activity in neuroblastoma: is it a prognostic indicator of clinical behaviour? Hiyama, E
 1997
 33 Supplement 8 p. 1932-1936
5 p.
 artikel
215 Telomere dynamics and telomerase activity in in vitro immortalised human cells Bryan, T.M.
 1997
 33 Supplement 8 p. 767-773
7 p.
 artikel
216 Teniposide, mitomicin C and cisplatin combination in treatment of advanced gastric cancer Bazin, I.
 1997
 33 Supplement 8 p. S279-S280
2 p.
 artikel
217 Ten-year results of treatment of ductal carcinoma in situ (DCIS) of the breast with conservative surgery and radiotherapy Amichetti, M.
 1997
 33 Supplement 8 p. 1559-1565
7 p.
 artikel
218 Testicular cancer: Human placental alkaline phosphatase (hPLAP) Pottek, T.S.
 1997
 33 Supplement 8 p. S43-
1 p.
 artikel
219 Testicular cancer — Staging, treatment and outcome Mead, G.M
 1997
 33 Supplement 8 p. S6-
1 p.
 artikel
220 The clinicopathological significance of K-RAS point mutation and gene amplification in endometrial cancer Esteller, M.
 1997
 33 Supplement 8 p. 1572-1577
6 p.
 artikel
221 The effect of human granulocyte and granulocyte macrophage-colony stimulating factors on neutrophil chemiluminesce Aydin, M.
 1997
 33 Supplement 8 p. S13-
1 p.
 artikel
222 The effect of the interval between surgery and radiotherapy on local control and overall survival in patients with breast cancer Özseker, N.
 1997
 33 Supplement 8 p. S84-
1 p.
 artikel
223 The effect of the neuroblastoma-seeking agent meta-iodobenzylguanidine (MIBG) on NADH-driven superoxide formation and NADH-driven lipid peroxidation in beef heart submitochondrial particles Cornelissen, J.
 1997
 33 Supplement 8 p. 421-424
4 p.
 artikel
224 The European prospective investigation into cancer, nutrition and health (EPIC) González, C.A.
 1997
 33 Supplement 8 p. S73-
1 p.
 artikel
225 The factors which influence the cosmetic outcome in breast cancer patients after conservative surgery and radiotherapy Özsaran, Z.
 1997
 33 Supplement 8 p. S105-
1 p.
 artikel
226 The implementation of nursing summarie Molin, C.M.
 1997
 33 Supplement 8 p. S316-
1 p.
 artikel
227 The importance of local control Rutqvist, L.E.
 1997
 33 Supplement 8 p. S216-
1 p.
 artikel
228 The nursing Advisor's role at the Norwegian cancer society's patient support center, Trondheim, Norway Bøe, Gina E.
 1997
 33 Supplement 8 p. S334-
1 p.
 artikel
229 The oncology nursing in Poland: How to survive and grow in the mean of change Krasuska, M.E.
 1997
 33 Supplement 8 p. S331-
1 p.
 artikel
230 The polymorphic enzymes N-acetyltransferase 2 and glutathione S-transferase M1 In bladder cancer patients Reckwitz, T.
 1997
 33 Supplement 8 p. S31-
1 p.
 artikel
231 The preventive effect of verapamil on radiation induced cataract: An experimental study Cengiz, M.
 1997
 33 Supplement 8 p. S108-
1 p.
 artikel
232 Therapeutic concepts for loco-regional recurrences in soft tissue sarcomas of the extremities Klein, P.
 1997
 33 Supplement 8 p. S116-
1 p.
 artikel
233 The relationship of human papillomavirus to p53 and proliferating cell nuclear antigen expression in head and neck cancer Kim, M.S.
 1997
 33 Supplement 8 p. S183-
1 p.
 artikel
234 The role of scientific nurse in management of clinical trials in chemotherapy department Zarouk, V.
 1997
 33 Supplement 8 p. S330-S331
2 p.
 artikel
235 The role of the nurse in palliative care Teunissen, S.C.C.M.
 1997
 33 Supplement 8 p. S222-
1 p.
 artikel
236 The start project: A European, evidence-based, state of the art instrument for clinical oncology Santoro, A.
 1997
 33 Supplement 8 p. S292-S293
2 p.
 artikel
237 The surgical management of screening detected and genetic breast cancer Holmberg, L.
 1997
 33 Supplement 8 p. S67-
1 p.
 artikel
238 The surgical procedure and the surgeon as a prognostic factor in gastric cancer van de Velde, C.J.H.
 1997
 33 Supplement 8 p. S71-
1 p.
 artikel
239 The U.K. national registry for radiation workers: Design, development and first analysis Kendall, G.M.
 1997
 33 Supplement 8 p. S25-S32
8 p.
 artikel
240 Thymidylate synthase (TS) and P53 as prognostic factors for patients (PTS) with colorectal cancer (CA) treated with adjuvant 5-fluorouracil (5FU) and levamisol (LEV) Van Triest, B.
 1997
 33 Supplement 8 p. S171-
1 p.
 artikel
241 Toxicity data of a multicenter, randomized study of standard FEC (FEC60) vs FEC with double epirubicin (EPI) (FEC120) plus G-CSF in metastatic breast cancer (MBC) Riccardi, A.
 1997
 33 Supplement 8 p. S157-
1 p.
 artikel
242 TP53 mutations in stage I gallbladder carcinoma with special attention to growth patterns Hanada, K.
 1997
 33 Supplement 8 p. 1136-1140
5 p.
 artikel
243 Transforming growth factors alpha & beta — Positive and negative regulators of epithelial growth Leake, Robin
 1997
 33 Supplement 8 p. S11-
1 p.
 artikel
244 Transplant-related morbidity (TRM) in patients undergoing bone marrow transplantation (BMT): The role of preparative regimens (PR) Giraud, Ph.
 1997
 33 Supplement 8 p. S91-
1 p.
 artikel
245 Treatment decisions in palliative cancer care: Patients' preferences for involvement and doctors' knowledge about it Rothenbacher, D
 1997
 33 Supplement 8 p. 1184-1189
6 p.
 artikel
246 Treatment of relapsing and refractory non-Hodgkin's lymphoma with a combination of dexamethasone, Ara-C, ifosfamide and cisplatin (DAIP) Haim, N.
 1997
 33 Supplement 8 p. S269-
1 p.
 artikel
247 Trends of in situ carcinoma of the breast in Vaud, Switzerland Levi, F.
 1997
 33 Supplement 8 p. 903-906
4 p.
 artikel
248 Types of failures after concomitant radio-chemotherapy and "boost in field" with or without surgery for locally advanced cervix cancer Nagy, V.
 1997
 33 Supplement 8 p. S209-
1 p.
 artikel
249 Use of Tc-99 labelled colloidal albumin for preoperative and intraoperative localization of non-palpable breast lesions Galimberti, V.
 1997
 33 Supplement 8 p. S79-
1 p.
 artikel
250 Vascular endothelial growth factors and receptors involved in angiogenesis and lymphangiogenesis Alitalo, Kari
 1997
 33 Supplement 8 p. S224-
1 p.
 artikel
251 Vinorelbine is well tolerated and active in the treatment of elderly patients with advanced non-small cell lung cancer. A two-stage phase II study Gridelli, C.
 1997
 33 Supplement 8 p. 392-397
6 p.
 artikel
                             251 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland